Please login first
The recent development of artificial intelligence-based cancer occurrence risk prediction models
1  Translation Informatics Center, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610212, Sichuan, China
2  Department of Computer Science and Information Technology, University of A Coruña, 15071, A Coruña, Spain
Academic Editor: MOL2NET Team

https://doi.org/10.3390/mol2net-09-14283 (registering DOI)
Abstract:

Artificial intelligence (AI) is playing an increasingly important role in developing cancer occurrence risk models. AI model can analyze vast amounts of data to identify patterns and correlations that may not be immediately apparent to clinicians, which can reduce overdiagnosis, timely identify risk factors, and lower incidence and mortality rates. This mini-review presented three specific articles that demonstrate the development process and application effectiveness of AI-based cancer occurrence risk models, providing inspiration and reference for future developments. These research allows for more accurate predictions of cancer risk based on a variety of factors such as imaging results, blood test result, etc. By identifying individuals at high risk for developing cancer, preventative measures can be taken to reduce their likelihood of developing the disease. Additionally, AI can help reduce overdiagnosis by distinguishing between benign and malignant conditions with greater accuracy. Overall, the use of AI in developing cancer risk models has the potential to greatly improve our ability to prevent and treat cancers.

Keywords: Artificial intelligence; machine learning; cancer risk prediction model; cancer prevention
Comments on this paper
Humbert G. Díaz
Dear author(s), Happy New Year 24, Thank you for your contribution to our conference!!!
We have a question for you, you can read and answer bellow.

Question for Authors:

Are there published reviews on Artificial Intelligence / Machine Learning (AI/ML) algorithms integrating clinical data with Rnomics data of these patients with already publishe proteomics, genomics data in this area?

REVIEWWWERS'23 participation:
We also invite you to participate in the REVIEWWWERS Workshop, which is now open, by making questions to other authors.
The steps are very easy. instructions: Step(1), Register/Login here [Register/Login] to Sciforum platform. Step(2), Go to presetations list [MOL2NET'23 Papers List], Step(3), Scroll down papers list and click on one title. Step(4), Scroll down and click on Commenting button, post your comment, and click submit. Step(5), Repeat review process for other papers. Step(6), Request certificate. See details [Reviewers Workshop] or contact us at Email: mol2net.chair@gmail.com.

Hari K.C.
- It would be more better if authors shows the architecture for AI based cancer risk prediction models.
- Discuss on the parameters of the dataset used by AI model



 
 
Top